Mark 21 nuclear bomb
The Mark 21 nuclear bomb was a United States nuclear gravity bomb first produced in 1955. It was based on the TX-21 "Shrimp" prototype that had been detonated during the Castle Bravo test in March 1954. While most of the Operation Castle tests were intended to evaluate weapons intended for immediate stockpile, or which were already available for use as part of the Emergency Capability Program, Castle Bravo was intended to test a design which would drastically reduce the size and costs of the first generation of air-droppable atomic weapons (the Mk 14, Mk 17 & Mk 24). At long, in diameter, and weighing , the Mk-21 was half the length and one-third the weight of the Mk-17/24 weapons it replaced. Its minimum yield was specified at four megatons.
Castle Bravo
Sir Joseph Rotblat, working at St Bartholomew's Hospital, London, demonstrated that the contamination caused by the fallout from the test was far greater than that stated officially. Rotblat was able to deduce that the bomb had three stages and showed that the fission phase at the end of the explosion increased the amount of radioactivity a thousandfold. Rotblat's paper was taken up by the media, and the outcry in Japan reached such a level that diplomatic relations became strained and the incident was even dubbed by some as a "second Hiroshima". Nevertheless, the Japanese and US governments quickly reached a political settlement, with the transfer to Japan of $15.3 million as compensation, with the surviving victims receiving about 2 million each ($5,550 in 1954, or about $ in 2022). It was also agreed that the victims would not be given Hibakusha status.